Evaluation of the Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of IN-C005 and IN-A001 in Healthy Caucasians

NCT05005065 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: IN-C005 X mg
DRUG: IN-A001 Y mg
DRUG: IN-C005 Y mg
DRUG: IN-C005 Z mg

Sponsor

HK inno.N Corporation